QUAINI, Federico
 Distribuzione geografica
Continente #
NA - Nord America 13.559
AS - Asia 12.117
EU - Europa 9.086
SA - Sud America 1.689
AF - Africa 615
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 20
Totale 37.118
Nazione #
US - Stati Uniti d'America 13.178
SG - Singapore 4.305
CN - Cina 3.458
VN - Vietnam 2.069
IT - Italia 1.465
IE - Irlanda 1.390
SE - Svezia 1.296
BR - Brasile 1.288
FI - Finlandia 1.209
DE - Germania 1.066
HK - Hong Kong 901
UA - Ucraina 667
FR - Francia 643
ZA - Sudafrica 399
NL - Olanda 353
TR - Turchia 313
GB - Regno Unito 257
CA - Canada 242
IN - India 217
AT - Austria 160
RU - Federazione Russa 148
AR - Argentina 146
BD - Bangladesh 140
BE - Belgio 94
MX - Messico 93
IQ - Iraq 83
CI - Costa d'Avorio 74
JP - Giappone 74
EC - Ecuador 73
PH - Filippine 68
CZ - Repubblica Ceca 65
PK - Pakistan 65
PL - Polonia 65
CO - Colombia 54
ID - Indonesia 53
KR - Corea 51
ES - Italia 48
TH - Thailandia 48
VE - Venezuela 42
UZ - Uzbekistan 40
MA - Marocco 35
SA - Arabia Saudita 30
AU - Australia 28
LT - Lituania 28
JO - Giordania 27
PY - Paraguay 27
IR - Iran 25
CH - Svizzera 24
TN - Tunisia 23
TW - Taiwan 22
KE - Kenya 21
CL - Cile 20
EG - Egitto 20
UY - Uruguay 19
EU - Europa 18
AZ - Azerbaigian 17
OM - Oman 15
MY - Malesia 13
AL - Albania 12
HU - Ungheria 11
IL - Israele 11
KZ - Kazakistan 11
NP - Nepal 11
PE - Perù 11
AE - Emirati Arabi Uniti 10
BG - Bulgaria 10
BY - Bielorussia 10
RO - Romania 10
BO - Bolivia 9
DZ - Algeria 9
ET - Etiopia 9
DO - Repubblica Dominicana 8
LU - Lussemburgo 8
RS - Serbia 8
LB - Libano 7
NG - Nigeria 7
GR - Grecia 6
HN - Honduras 6
JM - Giamaica 5
KG - Kirghizistan 5
KH - Cambogia 5
PA - Panama 5
PT - Portogallo 5
QA - Qatar 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
EE - Estonia 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BH - Bahrain 3
CR - Costa Rica 3
MD - Moldavia 3
MK - Macedonia 3
NI - Nicaragua 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
Totale 37.081
Città #
Singapore 2.234
Ashburn 1.574
Dublin 1.385
Chandler 1.322
San Jose 1.178
Dallas 996
Hong Kong 861
Beijing 795
Jacksonville 764
Santa Clara 691
Dearborn 631
Ho Chi Minh City 607
Parma 575
Boardman 496
Hanoi 470
Ann Arbor 445
Johannesburg 376
Nanjing 376
Munich 313
New York 307
Los Angeles 265
Lauterbourg 260
Shanghai 256
Princeton 253
Izmir 229
Wilmington 227
Helsinki 188
San Mateo 166
Hefei 141
Bremen 135
Vienna 133
Toronto 126
São Paulo 119
Jinan 112
Nanchang 102
Buffalo 95
Seattle 94
Kunming 93
Shenyang 93
Brussels 92
Haiphong 85
Da Nang 81
Abidjan 74
Hebei 74
Moscow 74
Changsha 73
Bologna 72
Frankfurt am Main 70
Milan 70
Council Bluffs 69
Columbus 68
Guangzhou 67
Des Moines 64
Turku 62
Tianjin 61
Padova 57
London 55
Jiaxing 54
Marseille 53
The Dalles 51
Atlanta 50
Tokyo 50
Chicago 49
Warsaw 49
Woodbridge 49
Brooklyn 48
Nuremberg 48
Houston 46
Montreal 45
Norwalk 40
Denver 39
Chennai 37
Hangzhou 37
Modena 36
Tulsa 36
Amsterdam 35
Baghdad 35
Zhengzhou 35
Orem 34
Tashkent 33
Biên Hòa 32
Hải Dương 32
Rio de Janeiro 32
Seoul 31
Belo Horizonte 29
Fremont 29
Lahore 29
Ningbo 29
Pune 29
Boston 28
Düsseldorf 28
Rome 28
Brno 27
Phoenix 27
Dong Ket 26
Jakarta 26
Poplar 26
Stockholm 26
Falkenstein 25
Quito 25
Totale 22.304
Nome #
Cobalt oxide nanoparticles induce oxidative stress and alter electromechanical function in rat ventricular myocytes 446
Effects of standardized green tea extract and its main component, EGCG, on mitochondrial function and contractile performance of healthy rat cardiomyocytes 269
Antiarrhythmic effect of growth factor-supplemented cardiac progenitor cells in chronic infarcted heart 260
Parenchymal and Stromal Cells Contribute to Pro-Inflammatory Myocardial Environment at Early Stages of Diabetes: Protective Role of Resveratrol 259
Comet assay and prediction of clinical outcome after DNA-damaging drugs treatment 259
Cardiac stem cell disease in diabetic cardiomyopathy: perspectives for preventing cardiac morpho-functional remodelling 243
Growth factor-induced mobilization of cardiac progenitor cells reduces the risk of arrhythmias, in a rat model of chronic myocardial infarction. 242
Titanium dioxide nanoparticles promote arrhythmias via a direct interaction with rat cardiac tissue 235
Acute Myocardial Infarction in Humans is Associated with Activation of Programmed Myocyte Cell Death in the Surviving Portion of the Heart 227
Subchronic exposure to titanium dioxide nanoparticles modifies cardiac structure and performance in spontaneously hypertensive rats 222
238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors 217
Diabetes impairs hematopoietic stem cell mobilization by altering niche function 215
Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors 215
1328P Dynamic blood immune-inflammatory and radiomic profiling to decode distinct patterns of acquired resistance to immunotherapy in NSCLC patients 214
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 209
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 208
Isolation and characterization of circulating tumor cells in advanced squamous-cell carcinoma of the lung 206
227P Sexual dimorphism in immune profile of early and advanced NSCLC 200
L’autofagia coinvolge i cardiomiociti e le cellule progenitrici nella cardiomiopatia indotta da imatinib mesilato 200
1352P A highly predictive blood-radiomics classifier in advanced NSCLC treated with immunotherapy 198
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC 193
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells. 188
Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart 186
Lymphangiogenesis in genetically determined hypertrophic obstructive cardiomyopathy 186
Preservation of ventricular performance at early stages of diabetic cardiomyopathy involves changes in myocyte size, number and intercellular coupling. 184
Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method 184
Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism. 182
Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors 182
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance 180
Bone Marrow Remodelling and Topographic Redistribution of CD34 Positive Progenitors Characterize the Progression of Myelodysplastic Syndromes and Their Evolution to AML 180
MESENCHYMAL STROMAL CELLS ISOLATED FROM DEFINED NSCLC CONTEXTURES REPRODUCE THE IMMUNE SIGNATURE OF THE PARENTAL MICROENVIRONMENT 179
Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. 178
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation 177
INTEGRATION OF TISSUE PD-1/PD-L1 IMMUNE CHECKPOINT WITH COMPUTED TOMOGRAPHY (CT) BASED TEXTURE ANALYSIS EXHIBITS HIGH PROGNOSTIC IMPACE ON SURGICALLY RESECTED NON SMALL CELL LUNG CANCER (NSCLC) 176
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC 176
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 176
189P The parallel interrogation of tissue and peripheral blood immune features unveils a bidirectional crosstalk with clinical impact on resected NSCLC 175
Amelioration of cardiac electrical performance following stem cell based regenerative therapies, in infarcted rat heart 175
LONGITUDINAL MONITORING OF RADIOMIC AND BLOOD IMMUNE-INFLAMMATORY DESCRIPTORS AS A NON-INVASIVE APPROACH TO PREDICT ICI EFFICACY IN ADVANCED NSCLC PATIENTS 174
The histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces cardiac arrhythmias in dystrophic mice. 174
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations. 173
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer 173
Aging and heart failure at the cellular and tissue levels. 173
Electrolyte Disorders Induced by Antineoplastic Drugs 172
Cancer treatment-induced cardiotoxicity: a cardiac stem cell disease? 170
17P Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients 170
P-027Cancer stem cells marker CD44 and Notch activation predict unfavorable prognosis in metastatic colon cancer patients treated with anti VEGF-therapy 169
Microsfere polimeriche funzionalizzate per terapie rigenerative cardiache mediate da cellule staminali. Test di biocompatibilità in vitro e in vivo. 168
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines 168
Repair of chronic myocardial infarction (MI) induced by mobilization of cardiac progenitor cells (CPCs) via local delivery of hapatocyte growth factor (HGF) and insulin-like growth factor-1 (IGF-1) is not proarrhythmic. 167
In Vitro Biological and Functional Properties of Human Endothelial Cells from Different Sources Exposed to Different Beta-Blockers 167
Development and validation of an high performance liquidchromatography–tandem mass spectrometry method for the determination of imatinib in rat tissues 166
Mobilization of cardiac progenitor cells by Hepatocyte Growth Factor (HGF) and Insulin-like Growth Factor-1 (IGF-1) for repairing chronic myocardial infarction (MI) is not proarrhytmic. 166
Trimethylamine-N-Oxide (TMAO)-Induced Impairment of Cardiomyocyte Function and the Protective Role of Urolithin B-Glucuronide 165
Cardiac regeneration by pharmacologically active microcarriers releasing growth factors and/or transporting adipose-derived stem cells 165
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 165
Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 164
Adult osteopetrosis: study of two brothers. 164
Hystone deacetylase inhibitors (HDACi) ameliorate cardiac elctrical competence in mdx mouse model of Duchenne muscular dystrophy (DMD). 163
The role of blood cholesterol quality in patients with advanced cancer receiving immune checkpoint inhibitors 162
BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL COMPONENT OF THE IMMUNE MICROENVIRONMENT AND ITS IMPACT ON NON SMALL CELL LUNG CANCER (NSCLC) CLINICAL OUTCOME 161
Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21 161
Cancer stem cells related marker CD44 and Notch activation in metastatic colon cancer patients 161
Resveratrol Treatment Reduces Cardiac Progenitor Cell Dysfunction and Prevents Morpho-Functional Ventricular Remodeling in Type-1 Diabetic Rats 160
Assessment of Cardiac Patches Suitability for Tissue Engineering 158
Imatinib Mesylate Induced Cardiotoxicity: a Cardiac Progenitor Cell Disease? 157
2315P Clinical and blood immune-inflammatory profiling to decode different patterns of acquired resistance in immunotherapy treated NSCLC patients 156
Deacetylase inhibitors reduce cardiac arrhythmogenesis in mdx mouse model of duchenne muscular dystrophy (DMD). 156
Cardiac regeneration by pharmacologically active microcarriers releasing growth factors and/or transporting adipose-derived stem cells 156
"Identification of differential resistance/sensitivity cellular mechanisms triggered by Gentuzumab Ozogamicin in Acute Myeloid Leukemia 156
Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN 156
Competenza funzionale elettrica del cuore rigenerato mediante mobilizzazione di cellule staminali cardiache residenti, in un modello di ratto con infarto miocardico cronico. 155
Dissecting the cellular mechanisms of cardiotoxicity by anthracycline and tyrosine kinase inhibitors 155
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 154
1929O Soluble PD-L1 and circulating CD8+PD1+ and NK cells enclose a highly prognostic and predictive immune effector score in immunotherapy treated NSCLC patients 153
Potential involvement of cardiac and bone marrow vascular progenitors in imatinib induced cardiovascular toxicity 153
Apoptosis in the Infarcted Human Heart 153
Cardiac electromechanical performance following stem cell based regenerative therapies in infarcted rat heart. 153
Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma 152
Longitudinal Changes of CT-radiomic and Systemic Inflammatory Features Predict Survival in Advanced Non–Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors 152
Electro-mechanical competence of regenerated heart in stem cell based therapy of myocardial infarction in rat model. 152
Isolation and characterization of human lung lymphatic endothelial cells 151
Diabetes Impairs Bone Marrow Microenvironment Affecting Progenitor Cell Number, Mobilization and Engraftment in Humans. 150
Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer 150
Clinico-Immunological Profile of a 67-Year-Old Woman Affected by HER2-Positive Breast Cancer and Autoimmune Dermatomyositis 149
Intersecting Blood Cytokines With Cholesterol Parameters to Profile Patients With Advanced Solid Tumors Receiving Immune Checkpoint Inhibitors 147
Resident cardiac stem cells. 145
Structural and Functional Characterization of the Hemolymphangiogenic Microenvironment in Lung Cancer 145
High-resolution X-ray microtomography for three-dimensional imaging of cardiac progenitor cell homing in infarcted rat hearts 144
Recent advances in cardiac hypertrophy 144
Bioactive Electrospun Fibers of Poly(glycerol sebacate) and Poly(ε-caprolactone) for Cardiac Patch Application 144
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 144
Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patients 144
Identification and tumorigenic role of Mesenchymal Stem Cells from human lung cancer 144
Social defeat and isolation induce clear signs of a depression-like state, but modest cardiac alterations in wild-type rats. 143
Notch Activation Modulates Bevacizumab Activity by CD44 Positive Cancer Stem Cells in Advanced Colon Cancer 143
Concise Review: Diabetes, the Bone Marrow Niche, and Impaired Vascular Regeneration. 142
Stem cells and myocardial regeneration 142
Apoptotic myocyte cell loss in failing human infarcted heart. 142
Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity 141
Totale 17.723
Categoria #
all - tutte 122.545
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.545


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021435 0 0 0 0 0 0 0 0 0 86 285 64
2021/20221.234 36 40 22 73 35 26 187 165 52 81 101 416
2022/20235.406 541 576 381 378 519 609 88 334 1.673 17 207 83
2023/20242.138 111 170 48 66 190 518 196 141 74 148 179 297
2024/20256.683 155 360 480 463 700 624 326 337 771 581 545 1.341
2025/202613.955 1.289 1.357 1.879 1.420 1.962 770 1.564 551 2.139 1.024 0 0
Totale 37.422